Although neuromuscular blocking agents (NMBAs), such as pancuronium bromide and succinylcholine, are widely used in the management of critically ill patients, many misconceptions regarding the agents’ clinical effects and indications persist. This article will discuss these misconceptions and review the indications for the use of NMBAs in the critically ill patient, how these potent agents work, and strategies to effectively manage critically ill patients who are receiving NMBAs as a part of their treatment regimen
Skip Nav Destination
Analgesia and Sedation in the Critically Ill Patient| November 01 1991
Neuromuscular Blocking Agents in the Critically Ill Patient: Neither Sedating nor Pain Relieving
Lorie Rietman Wild, RN, MN
From the Department of Anesthesiology, University of Washington Medical Center, University of Washington School of Medicine, Seattle, Washington.
Reprint requests to Lorie Wild, RN, MN, Department of Anesthesiology, University of Washington Medical Center, 1959 NE Pacific, RN-10, Seattle, WA 98195.
Search for other works by this author on:
AACN Adv Crit Care (1991) 2 (4): 778–787.
Lorie Rietman Wild; Neuromuscular Blocking Agents in the Critically Ill Patient: Neither Sedating nor Pain Relieving. AACN Adv Crit Care 1 November 1991; 2 (4): 778–787. doi: https://doi.org/10.4037/15597768-1991-4017
Download citation file:
Don't already have an account? Register